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betic patients undergoing cardiac surgery.
Objective: Is to estimate the relation between blood glucose control and perioperative outcomes in
these patients.
Study design: Prospective cohort study.
Methods: One hundred diabetic patients undergoing cardiac surgery, were divided equally into
group I (control group) in whom no tight glycemic control was done and group II (study group)
in which tight glycemic control was done. Patients in the study group received intra-operatively
an infusion of rapidly acting insulin according to a modiﬁed protocol to keep blood glucose level
between 80 and 110 mg/dl and continued in the ICU until complete recovery from anesthesia.
Patients in the control group followed the same protocol of insulin infusion only if their peri-
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72 S.M. Asida et al.Results: There was a rise of blood glucose level in the control group patients till the end of oper-
ations (mean level = 227 mg/dl). Mean blood glucose level before CPB was comparable in the two
groups, but was signiﬁcantly different after that until extubation. We reported three cases of
delayed recovery in the control group compared to one case in the study group. We also recorded
four cases of cardiac problems in group I compared to one case in group II (P= 0.044). There was
statistically signiﬁcant difference between groups regarding renal, neurological and surgical post-
operative complications.
Conclusion: Tight glycemic control is recommended for better patient’s outcome after cardiac anes-
thesia.
ª 2012 Egyptian Society of Anesthesiologists. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
Diabetes mellitus is a common metabolic and endocrine disor-
der among the Egyptian population. It represents an indepen-
dent risk factor for morbidity and mortality in patients
undergoing cardiac surgery [1,2]. The severity and duration
of diabetes in the diabetic patient determines the severity of
complications associated with diabetes such as diabetic periph-
eral neuropathy, renal dysfunction, fatty liver, optic neuropa-
thy, accelerated atherosclerosis and hypertension. These
pathophysiologic changes have their impact on the course of
anesthesia and surgery specially cardiac surgery and cardiopul-
monary bypass [3]. Studies showed that a fraction of non-
diabetic patients were found to have glucose intolerance due
to the stressful situation of anesthesia and cardiopulmonary
bypass [4,5]. Recent studies showed that although tight eugly-
cemic control has its beneﬁcial effect on reducing neurological
and infectious complications yet this was offset by the possibil-
ity of hypoglycemia which is more dangerous in case of general
anesthesia in the short term view [6].
In a trial to improve the outcome of our practice of cardiac
anesthesia and to decrease the length of hospital stay to reduce
the costs, we conducted this bi-center study to investigate the
value of continuous strict control of blood glucose level peri-
operatively on the patient’s outcome and the incidence of com-
plications whether anesthetic or surgical.2. Patients and methods
This cohort study was done in Qena, and Mansoura university
hospitals from January 2010 to may 2011. It was approved by
the ethics committee of Qena and Mansoura faculties of med-
icine written informed consent was taken from all patients to
share in the study. We conducted this study on 100 patients
randomly assigned to two groups (50 patients in each group)
according to a computer-generated allocation table (graph
pad software) [7]. We included patients above 18 years old
and below 60 years old: American Society of Anesthesiologists
(ASA) classes II and III. Admitted for different cardiac surgi-
cal procedures and known to be diabetic. All patients whether
insulin dependent or non insulin dependent (on oral hypogly-
cemic therapy) were shifted to insulin therapy using short act-
ing insulin to control blood glucose (80–110 mg/dl fasting and
up to 140 mg/dl random) 2 days before operation as a routine
hospital protocol of pre-operative preparation of patients. We
recognized diabetic patient if fasting (8 h fasting) blood glucoselevel above 140 mg/dl was measured pre-operatively even if the
patient was not treated before surgery for control of high
blood sugar (according to the consensus criteria) [8]. We also
excluded patients with renal impairment (creatinine level more
than 1.6 mg/dl) in whom hyperkalemia may be present that
may require insulin – glucose for correction of hyperkalemia.
We also excluded patients undergoing off-pump surgery.
The day before surgery, pre-operative evaluation of patients
was done which included medical history, clinical examination,
chest X-ray examination, ECG, data of cardiac catheterization,
echocardiography and laboratory investigations (complete
blood count, bleeding time, clotting time, prothrombin time,
partial thromboplastin time, blood sugar, Hemoglobin A1c,
liver function tests, renal function tests, and urine analysis.
Then the study protocol was explained to every patient and
consent was taken from him or her.
The anesthetic technique was the same for all patients in the
study, starting by pre-operative re-examination of the patient,
and re-checking his ﬁle.
On arrival to the operating room, in the fasting patient a
venous cannula (22 Gauge) was inserted in the non-dominant
forearm under complete aseptic technique and 1–2 mg midaz-
olam was injected through it. The non-dominant radial artery
cannulation is performed under local anesthesia using lido-
caine 2% after doing modiﬁed Allen’s test, followed by inser-
tion of thoracic epidural catheter with injection of 2–5 mg
morphine\ [What were the criteria on which epidural morphine
dose range (2–5 mg) based?] (this is from our current practice
and clinical experience, variation according to body weight,
height, general condition and pre-operative echocardiography
data of each patient) diluted with sterile saline solution to
10 ml volume. The patient was put in the sitting position, the
anesthetist wearing sterile gloves painted the patient’s back
with antiseptic solution, the site of epidural needle entry (mid-
line – at the level of the line joining the lower angle of the two
scapulae) was inﬁltrated with 2 ml lidocaine 2% using sterile
ﬁne needle of insulin syringe (least painfull) before advancing
the epidural needle with loss of resistance test applied till
reaching the epidural space.
We gave IV fentanyl at a dose 5-lg/kg, this dose is reduced
because patients received thoracic epidural morphine pre-
induction of anesthesia, we gave half the dose at induction
and a quarter at skin incision and the last quarter before
sternotomy. We induced anesthesia with 1–2 mg/kg propofol
followed by 0.5 mg/kg atracurium intravenously. After intuba-
tion, patients were mechanically ventilated through volume-
controlled ventilation with 100% O2 to maintain the end-tidal
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(aided by the epidural morphine) and proceeded for central line
cannulation of the right internal jugular vein with a 2-way CVP
catheter.
2.1. Monitoring
During all procedures, HR, rhythm and computerized ST seg-
ment analysis were monitored, pulse oximetry, capnography,
CVP, continuous arterial blood pressure (using NIHON
KOHDEN monitor – Japan) and activated clotting time
(ACT) using hemochron 801 apparatus. Urine output was
monitored via urinary catheter. Skin and nasopharyngeal
temperature was continuously monitored with thermoster
probe.
2.2. Surgical technique
The heart was approached through a standard median sternot-
omy in all patients. Heparin 300–400 IU/kg was administered
i.v. then the ascending aorta, SVC and IVC were cannulated.
Cardiopulmonary bypass (CPB) was started when the acti-
vated clotting time (ACT) reached more than 400 seconds
using a non-pulsatile pump ﬂow rate of 2–2.5 l/m2/min. Mod-
erate hemodilution with a crystalloid prime and moderate sys-
temic hypothermia (to a lowest temperature of 28 C) were
used. After aortic cross clamping, myocardial protection was
achieved with intermittent antegrade cold blood cardioplegia
through the aortic root till cardiac arrest occurred and re-
peated every 25–30 min or on the return of electrical activity
of the heart. Myocardial cooling using packed iced saline
was done. Hematocrit concentration (HCT) was maintained
between 20% and 25%, with addition of blood as necessary.
Patients were actively rewarmed to 38 C before removal of
the aortic cross-clamp. Separation from CPB was accom-
plished with i.v. epinephrine 50–100 ng/kg/min or dobutamine
(5–10 lg/kg/min) according to the anesthesiologist managing
the case. Heparinization was reversed with an initial dose of
i.v. protamine sulfate (0.8–1 mg for 100 IU of heparin admin-
istered). An additional dose of 0.5–1 mg/kg of protamine sul-
fate was given when the ACT remained above 140 s.
Cardiopulmonary bypass was handled by a perfusionist as
appropriate with cooperation of the anesthesia team. Serial
arterial blood gas analysis and activated clotting time are done
as appropriate.
How frequent were you measuring blood sugar in both
groups?
Blood glucose was measured (venous blood samples with-
drawn and sent to the hospital lab for blood glucose level) just
before induction of anesthesia, before skin incision, before ini-
tiation of cardio-pulmonary by-pass, every 20 min after start
of by-pass till the patient was transferred to the intensive care
unit where blood glucose level is measured every 2 h until extu-
bation is done. After extubation blood glucose was monitored
every 4 h routinely.
How was blood sugar managed in the control group?
In the control group (group I) no insulin was given to the
patient unless blood glucose level exceeded 180 mg/dl. If so,
we initiated an infusion of rapidly acting insulin (act rapid)
in saline of 6–9 units/h using syringe pump and adjusted the
rate of infusion to keep glucose level between 110 and
180 mg/dl [8,9].While in the study group (group II) where tight glycemic
control of glucose level between 80 and 110 mg/dl was targeted
we gave a continuous infusion of insulin in saline (50 units of
rapidly acting insulin (act rapid) in 50 ml syringe) at a rate of
1–2 units/h if blood glucose between 110 and 150 mg/dl. If
blood glucose level was between 150 and 200 mg/dl we in-
creased the rate of insulin infusion to 4–6 units/h. And if it ex-
ceeded 200 mg/dl then the insulin infusion rate was 6–9 units/h
[from where you got this IV insulin dose 6–9 units/h? I guess
from Ref. #9] [this insulin infusion protocol was modiﬁed from
Cammu et al. [9]].
Post-operative care was standardized for all patients and in-
cluded epidural morphine (2–3 mg every 8 h) and i.v. midazo-
lam for sedation prior to tracheal extubation when
hypertension, tachycardia and/or excessive patient movement
occurred. Midazolam was given (increments of 1–2 mg). Seda-
tion was maintained until normothermia, hemodynamic stabil-
ity and minimal chest tube drainage then extubation was done.
The criteria for extubation included normal neurologic status
(Glasgow coma scale above 13), stable hemodynamics under
minimal inotropic support (<5 lg/kg/min dopamine or dobu-
tamine and <50 ng/kg/min epinephrine), adequate pulmonary
function (spontaneous ventilation with SIMV for a minimum
of 30 min (exhaled tidal volume 6–10 ml/kg), respiratory rate
between 12 and 20 breaths/min, PaCO2 < 50 mmHg, pH >
7.3, PaO2 > 75 mmHg on FiO2 < 40%), normothermia, ade-
quate urine output and minimal chest tube drainage (<50 ml/
h). After extubation, oxygen was delivered to patients through
nasal cannula 2–4 ml/min for 24 h. ICU discharge criteria in-
cluded patient orientation, hemodynamic stability without ino-
tropic or vasoactive drugs, SaO2 > 90% on FiO2 < 0.5, no
uncontrolled arrhythmia, urine output P0.5 ml/kg/h. Chest
tube, CVP and arterial lines were removed before transfer to
the ward.
We followed our patients in the ICU for immediate and de-
layed post-operative problems including pulmonary complica-
tions such as pneumothorax, atelectasis and pleural effusion
(by serial X-ray chest examinations).
Neurological complications were also recorded, as well as
renal dysfunction diagnosed by any increase of creatinine con-
centration more than 2 mg/dl.
Surgical bleeding was conﬁrmed if it exceeds 200 ml/h or
1000 ml/day. Infection was diagnosed by lecuocytosis or posi-
tive culture of: blood, mediastinal or pleural ﬂuid or urine or
discharge from the wound.
Were you able to follow all the 100 patients for 6 months?
All patients were followed up for 6 months for each case
using a follow up card through post-operative visits (a weekly
visit to the cardiac surgery outpatient clinic in the two surgery
departments in Qena and Mansoura or a telephone call con-
tact along 6 months), and data collected from the surgeons
[You did not mention the mortality rate if any?], and there
were no recorded mortality nor morbidity other than men-
tioned in the results.
2.3. Statistical analysis
Sample size calculation was done using online power/sample
size calculator (http://www.stat.ubc.ca), we assumed the inci-
dence of adverse events to be 35% according to previously
published data [10] and we tested for the frequency of adverse
events of 20% considering a= 0.05 and power of 0.8, this re-
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statistical analysis, categorical data were compared between
the two groups by Chi Square test, parametric data were com-
pared between the two groups by un-paired t-test. Mann–
Whitney test was used for non-parametric data. Results were
considered signiﬁcant if P value less than 0.05.
3. Results
This study was done on 100 patients admitted for different car-
diac surgical procedures not involving off-pump surgery. Pa-
tients were divided into two groups 50 patients in each
group, In group I no tight glycemic control was done, In group
II tight glycemic control was done. Patient’s characteristics
were comparable in the two groups. We had two patients in
group I and 1 patient in group II with history of myocardial
infarction. We had also ﬁve patients in group I and six patients
in group II on treatment for hypertension. No statistically sig-
niﬁcant difference was found regarding mean CPB time and
length of hospital stay, Table 1.
The total number of cases with complications in the control
group was 21 and was seven cases in the study group, this was
statistically signiﬁcant.
Mean blood glucose level before induction of anesthesia and
before start of CPB was comparable, but after CPB there was
statistically signiﬁcant difference between the two groups at all
measurement points until extubation, Fig. 1.
Delayed recovery (extubation done in the next day of oper-
ation) was recorded in three cases in group I (6%) and one case
(2%) in group II, these cases required inotropic support for
more than 6 h post-operatively and extubation was performedTable 1 Patient’s characteristics.
Variable Group I no =
Age in years 49 ± 8
Weight in kg 86 ± 2
Height in cm 169 ± 4
Body mass index 26 ± 2
Sex (male/female) 35/15
Pre-op. blood glucose level 155 ± 23
Length of hospital stay (h) 88 ± 5
1-History of:
Smoking 20 ± 2
Hypertension 5
CAD 12
MI 2
LVEF % 52 ± 4
AF 4
COPD 3
Stroke 2
Renal impairment 1
2-type of operation:
CABG 12
ASD repair 15
Mitral valve replacement 23
3-Cardio-pulmonary bypass time-minutes 55 ± 16
CAD= coronary artery disease, MI =Myocardial infarction, LVE
COPD= chronic obstructive pulmonary disease, CABG= coronary art
Data are expressed as mean ± standard deviation (SD) or number.on the second day of operation (after 18 h of intubation). We
found statistically signiﬁcant difference between the two
groups (Table 2).
In group I there was four cases (8%) in whom cardiac prob-
lems were reported in the form of return of atrial ﬁbrillation, in
group II we have seen one case of atrial ﬁbrillation and the
other suffered from acute myocardial infarction. We found
no signiﬁcant difference between the two groups.
We recorded pulmonary problems in ﬁve cases in group I
(10%) and 2 cases (4%) in group II. Prolonged bronchospasm
occurred in three cases in group I, pneumothorax was found
in the two cases in group II, bronchitis was recorded in two cases
in group I. We found no signiﬁcant difference between the two
groups.
Elevated serum creatinine was reported in three cases (6%)
in group I compared to one case (2%) in group II (measured
the second day of operation). This was statistically signiﬁcant.
We recorded two cases of post-operative delirium and one
case of stroke 4 days after operation. No neurological compli-
cations were recorded in group II. This was statistically signif-
icant difference.
Surgically we had three cases (6%) of re-do operation for
bleeding in group I and one case in group II (2%) (Table 2).
Again we found statistically signiﬁcant difference between
the two groups.
4. Discussion
We conducted this study to investigate the effect of blood glu-
cose level on the course and outcome of cardiac anesthesia and
surgery. We put in mind how to improve outcome and decrease50 Group II no = 50 P value
46 ± 9 0.24
83 ± 4 0.33
167 ± 2 0.09
28 ± 0.8 0.88
30/20 0.06
147 ± 15 0.07
83 ± 3 0.078
17 ± 5 0.07
6 0.07
13 0.06
1 0.051
57 ± 7 0.04
3 0.12
1 0.048
- –
3 0.022
13 0.06
17 0.44
20 0.23
59 ± 11 0.66
F = left ventricular ejection fraction, AF = atrial ﬁbrillation,
ery by-pass graft, ASD= atrial septal defect.
Figure 1 Mean blood glucose level in the two groups (mg/dl). Group I: control group. Group II: tight control group. \ = P
value > 0.05.
Table 2 Post-operative events and complications in the two
groups.
Post-operative events Group I n= 50 Group II n= 50 P value
Delayed recovery 3 Cases 1 Case 0.039*
Pulmonary problems 5 Cases 2 Cases 0.92
Cardiac problems 4 Cases 2 Cases 0.44
Renal problems 3 Cases 1 Case 0.04*
Neurological problems 3 Cases 0 0.032*
Surgical problems 3 Cases 1 Case 0.033*
Total number of cases 21 Cases 7 Cases 0.034*
* =Statistically signiﬁcant = P value < 0.05.
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at the end in reduction of length of hospital stay and decrease
the cost of these operations both for the hospital and the patient.
Hyperglycemia is considered an important risk factor that
contributes to intra and post-operative complications such as
infection e.g. wound infection, urinary tract infection, or septi-
cemia [11]. It can be blamed also for the occurrence of stroke,
prolonged mechanical ventilation, heart block, cardiac arrest
and even death [12].
It has been shown that hyperglycemia is a leading cause for
the formation of abnormal proteins through non-enzymatic
glycosylation that worsens neurological injury after focal and
global cerebral ischemia through anaerobic transformation
of glucose to lactate which impairs cellular metabolism [6].
We used insulin infusion in both groups according to a
modiﬁed protocol [9] but we did not give insulin in the control
group unless blood glucose level exceeded 200 mg/dl for pa-
tient safety. This occurred early in the ICU at the end of oper-
ation, otherwise we did our best to control blood glucose level
in the study group between 80 and 110 mg/dl.
It seems from the data you submitted that patients in gp 2
had a signiﬁcantly better myocardial function and less of pul-
monary dysfunction, do you think this impacted on their post-
operative course?
The results of follow up of the patients in the two groups
showed no statistically signiﬁcant difference regarding cardiacand pulmonary problems (patients in the study group showed
better myocardial and pulmonary functions which was
reﬂected on the post-operative course, while renal, neurological,
and surgical problems showed statistically signiﬁcant difference
between the two groups. This is most probably due to the fact
that cardio-respiratory problems are more related to the nature
of surgical intervention and the mean cardio-pulmonary by-pass
time (CPB) that were comparable in the two groups. The de-
layed recovery that was recorded in the two groups was statis-
tically signiﬁcant. It was associated with hemodilution and
prolonged mechanical ventilation. These results support our
assumption that tight glycemic control is beneﬁcial for reduc-
tion of post-operative complications regarding neurological, re-
nal and surgical events but it did not differ much regarding
cardiopulmonary complications.
What helped us in controlling blood glucose level during
operation is that we completely avoided glucose-containing
solutions and insulin was diluted in normal saline in contrast
to what Azarfarin et al. [13] has done; they gave dextrose
5% solutions and left the surgeon to give dextrose 5% solution
in the post-operative period because they wanted to avoid
hypoglycemia. However they reported at least one attack of
hyperglycemia (above 180 mg/dl) in 55% of non-diabetic pa-
tients during the ﬁrst 24 h after CABG surgery.
We have a number of published studies about the role of
blood glucose level control in improving outcome and reduc-
ing morbidity after cardiac surgery. Chaney et al. in 1999 [6]
reported that the attempt to control blood glucose level carries
the risk of hypoglycemia, this ﬁnding was not found in our
study and on the contrary we found an attempt of blood
glucose to rise in the two groups specially during CPB period
and in the ICU.
Gandhi et al. [1] found a relation between adverse events
and intra-operative glucose concentrations. They reported that
for each 20 mg/dl increase in blood glucose level above
100 mg/dl there is 34% increase in the incidence of post-oper-
ative complications. In our study the total number of cases
with complications was signiﬁcantly different in the two
groups suggesting a strong relation between blood glucose
level control and the occurrence of complications though we
did not evaluate this relation as Gandhi et al. did.
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non-diabetic patients found no difference between diabetic
and non-diabetic regarding morbidity and mortality but at
the same time they found that diabetic patients stay longer
time in the ICU if their blood glucose level was not controlled.
In our study no difference was found between the two groups
as all our patients were diabetic and although there was statis-
tically signiﬁcant difference regarding morbidity yet the overall
mortality was not different.
Arabi et al. [14]conducted one of the few studies on inten-
sive insulin therapy for patients in medical and surgical ICU
and they reported no improvement in survival and that inten-
sive insulin therapy was associated with increased risk of hypo-
glycemia. This is not in agreement with our study as we did not
ﬁnd any case of hypoglycemia in all patients in the two groups
although we followed a protocol to strictly keep blood glucose
level between 80 and 110 mg/dl in the study group.
Azarfarin et al. in 2011 [15] studied the effect of blood glu-
cose control in non-diabetic patients undergoing CABG sur-
gery, they found that blood glucose level is increased in these
patients though they were not diabetic pre-operatively and that
controlling blood glucose level in the study group between 110
and 126 mg/dl is required as it decreased the incidence of com-
plications from 32% in the control group to 16% in the study
group. In our study all patients in the two groups were diabetic
and we evaluated the effect of blood glucose control on pa-
tient’s outcome, it can be considered as a continuation of the
study of Azarfarin as we found that blood glucose control is
essential in diabetic patients as Azarfarin found this control
essential for non-diabetic patients.
In conclusion we found that intra-operative tight glycemic
control is more beneﬁcial than wide glycemic control in diabetic
patients subjected to open heart surgery for decreasing the inci-
dence of post-operative complications as regard to recovery
criteria, renal, and neurological complications. However, there
was no effect on length of hospital stay between both regimens.
Recommendation: We think that long term follow up on a
wider scale of patients may be needed to assure this regimen as
standard protocol in cardiac anesthesia of diabetic patients
with no fear of hypoglycemia if close monitoring of blood
glucose level is done to maintain eu-glycemic stability.
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